[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 23, Issue 3 (9-2021) ::
2021, 23(3): 203-215 Back to browse issues page
Relationship between Spexin Neuropeptide and Cardiovascular Risk Factors in Children and Adolescents: A Systematic Review
Y Khorshidi , G Asghari , P Mirmiran
Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran , g_asghari@hotmail.com
Abstract:   (1210 Views)
Introduction: Spexin, a novel neuropeptide with diverse physiological functions, can be a cardiovascular disease risk assessment biomarker. This study investigated the association between serum spexin concentration and cardiovascular risk factors in children and adolescents. Materials and Methods: A search was conducted to collect studies between January 2007 and March 2021 in the PubMed, Embase, and Scopus databases. The keywords "neuropeptide Q" and "spexin," along with keywords related to diabetes, inflammation, metabolic syndrome, and cardiovascular disease, were used for the search. Results: A total of 11 full-text articles were included in the study. In six of the studies, the spexin level was lower in obese children and adolescents than in normal-weight individuals, and the difference was significant in four of them (p <0.05). An inverse relationship was observed between spexin and insulin resistance in six of the studies; however, no correlation was found between spexin and glucose in the studies. The results were contradictory regarding inflammation, but the positive correlation of spexin with anti-inflammatory agents showed the anti-inflammatory effects of this neuropeptide. Five of the studies investigated the relationship between spexin and cardiovascular diseases such as hypertension, and three of them showed a positive role for spexin in cardiovascular health. Also, one of the studies examined the effect of spexin on metabolic syndrome and confirmed the protective role of spexin. Conclusion: It seems that this neuropeptide positively affects metabolic status, especially weight control and insulin resistance, in children and adolescents.
Keywords: Spexin, Cardiovascular risk factors, Obesity, Children, Adolescents
Full-Text [PDF 1206 kb]   (597 Downloads)    
Type of Study: Review | Subject: Cardiology
Received: 2021/09/19 | Accepted: 2022/01/2 | Published: 2021/09/1
attachement [JPG 1029 KB]  (35 Download)
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khorshidi Y, Asghari G, Mirmiran P. Relationship between Spexin Neuropeptide and Cardiovascular Risk Factors in Children and Adolescents: A Systematic Review. Iranian Journal of Endocrinology and Metabolism 2021; 23 (3) :203-215
URL: http://ijem.sbmu.ac.ir/article-1-2905-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 3 (9-2021) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4642